nodes	percent_of_prediction	percent_of_DWPC	metapath
Estramustine—Alkylating Activity—Melphalan—breast cancer	0.118	0.333	CiPCiCtD
Estramustine—Alkylating Activity—Chlorambucil—breast cancer	0.118	0.333	CiPCiCtD
Estramustine—Alkylating Activity—Thiotepa—breast cancer	0.118	0.333	CiPCiCtD
Estramustine—ESR2—breast cancer	0.0674	0.456	CbGaD
Estramustine—Estradiol—Fulvestrant—breast cancer	0.0651	0.372	CrCrCtD
Estramustine—ESR1—breast cancer	0.0415	0.281	CbGaD
Estramustine—ESR2—Fulvestrant—breast cancer	0.0329	0.146	CbGbCtD
Estramustine—MAP2—Paclitaxel—breast cancer	0.0325	0.144	CbGbCtD
Estramustine—Conjugated Estrogens—Exemestane—breast cancer	0.0325	0.186	CrCrCtD
Estramustine—Estropipate—Exemestane—breast cancer	0.0325	0.186	CrCrCtD
Estramustine—Estrone—Exemestane—breast cancer	0.0241	0.138	CrCrCtD
Estramustine—MAP2—Docetaxel—breast cancer	0.0235	0.104	CbGbCtD
Estramustine—CYP3A4—breast cancer	0.0212	0.143	CbGaD
Estramustine—ESR2—Raloxifene—breast cancer	0.0196	0.0868	CbGbCtD
Estramustine—ESR1—Toremifene—breast cancer	0.0181	0.0804	CbGbCtD
Estramustine—ESR1—Fluoxymesterone—breast cancer	0.0181	0.0804	CbGbCtD
Estramustine—ABCB1—breast cancer	0.0176	0.119	CbGaD
Estramustine—ESR1—Fulvestrant—breast cancer	0.0169	0.0748	CbGbCtD
Estramustine—ESR2—Tamoxifen—breast cancer	0.0129	0.0574	CbGbCtD
Estramustine—Testosterone—Exemestane—breast cancer	0.0123	0.0704	CrCrCtD
Estramustine—ESR1—Raloxifene—breast cancer	0.01	0.0445	CbGbCtD
Estramustine—Testosterone—Fluoxymesterone—breast cancer	0.00854	0.0488	CrCrCtD
Estramustine—ESR1—Tamoxifen—breast cancer	0.00662	0.0294	CbGbCtD
Estramustine—ABCB1—Toremifene—breast cancer	0.00311	0.0138	CbGbCtD
Estramustine—CYP3A4—Exemestane—breast cancer	0.00269	0.0119	CbGbCtD
Estramustine—CYP3A4—Letrozole—breast cancer	0.00228	0.0101	CbGbCtD
Estramustine—ABCB1—Lapatinib—breast cancer	0.00227	0.0101	CbGbCtD
Estramustine—CYP3A4—Anastrozole—breast cancer	0.00204	0.00903	CbGbCtD
Estramustine—CYP3A4—Toremifene—breast cancer	0.00186	0.00826	CbGbCtD
Estramustine—CYP3A4—Fulvestrant—breast cancer	0.00173	0.00768	CbGbCtD
Estramustine—CYP3A4—Thiotepa—breast cancer	0.00154	0.00685	CbGbCtD
Estramustine—MAP1A—mammary gland—breast cancer	0.00143	0.0913	CbGeAlD
Estramustine—CYP3A4—Ixabepilone—breast cancer	0.00141	0.00626	CbGbCtD
Estramustine—CYP3A4—Lapatinib—breast cancer	0.00136	0.00603	CbGbCtD
Estramustine—ABCB1—Vinorelbine—breast cancer	0.00126	0.00558	CbGbCtD
Estramustine—ABCB1—Tamoxifen—breast cancer	0.00114	0.00504	CbGbCtD
Estramustine—ABCB1—Mitoxantrone—breast cancer	0.00111	0.00491	CbGbCtD
Estramustine—CYP3A4—Raloxifene—breast cancer	0.00103	0.00457	CbGbCtD
Estramustine—ABCB1—Gemcitabine—breast cancer	0.000978	0.00434	CbGbCtD
Estramustine—MAP1A—embryo—breast cancer	0.000978	0.0623	CbGeAlD
Estramustine—ABCB1—Paclitaxel—breast cancer	0.000884	0.00392	CbGbCtD
Estramustine—ABCB1—Irinotecan—breast cancer	0.000872	0.00387	CbGbCtD
Estramustine—ABCB1—Vinblastine—breast cancer	0.000775	0.00344	CbGbCtD
Estramustine—CYP3A4—Vinorelbine—breast cancer	0.000754	0.00334	CbGbCtD
Estramustine—CYP3A4—Tamoxifen—breast cancer	0.00068	0.00302	CbGbCtD
Estramustine—MAP2—nipple—breast cancer	0.000674	0.0429	CbGeAlD
Estramustine—CYP3A4—Mitoxantrone—breast cancer	0.000664	0.00294	CbGbCtD
Estramustine—MAP1A—uterus—breast cancer	0.00066	0.042	CbGeAlD
Estramustine—MAP1A—pituitary gland—breast cancer	0.000648	0.0413	CbGeAlD
Estramustine—MAP1A—adipose tissue—breast cancer	0.000645	0.0411	CbGeAlD
Estramustine—ABCB1—Docetaxel—breast cancer	0.000639	0.00283	CbGbCtD
Estramustine—MAP1A—adrenal gland—breast cancer	0.000579	0.0369	CbGeAlD
Estramustine—MAP2—embryo—breast cancer	0.000556	0.0354	CbGeAlD
Estramustine—MAP1A—female gonad—breast cancer	0.00054	0.0344	CbGeAlD
Estramustine—CYP3A4—Paclitaxel—breast cancer	0.00053	0.00235	CbGbCtD
Estramustine—ESR2—mammary gland—breast cancer	0.000528	0.0336	CbGeAlD
Estramustine—CYP3A4—Irinotecan—breast cancer	0.000522	0.00232	CbGbCtD
Estramustine—MAP1A—endocrine gland—breast cancer	0.000502	0.032	CbGeAlD
Estramustine—ABCB1—Doxorubicin—breast cancer	0.000476	0.00211	CbGbCtD
Estramustine—CYP3A4—Vinblastine—breast cancer	0.000464	0.00206	CbGbCtD
Estramustine—ABCB1—Methotrexate—breast cancer	0.000461	0.00205	CbGbCtD
Estramustine—MAP2—endometrium—breast cancer	0.000407	0.0259	CbGeAlD
Estramustine—CYP3A4—Docetaxel—breast cancer	0.000383	0.0017	CbGbCtD
Estramustine—MAP2—pituitary gland—breast cancer	0.000368	0.0234	CbGeAlD
Estramustine—MAP2—adipose tissue—breast cancer	0.000367	0.0233	CbGeAlD
Estramustine—ESR1—mammary gland—breast cancer	0.000361	0.023	CbGeAlD
Estramustine—MAP1A—lymph node—breast cancer	0.000347	0.0221	CbGeAlD
Estramustine—MAP2—female reproductive system—breast cancer	0.000337	0.0215	CbGeAlD
Estramustine—MAP2—adrenal gland—breast cancer	0.000329	0.0209	CbGeAlD
Estramustine—MAP2—female gonad—breast cancer	0.000307	0.0195	CbGeAlD
Estramustine—ESR2—epithelium—breast cancer	0.000294	0.0187	CbGeAlD
Estramustine—CYP3A4—Doxorubicin—breast cancer	0.000285	0.00127	CbGbCtD
Estramustine—MAP2—endocrine gland—breast cancer	0.000285	0.0182	CbGeAlD
Estramustine—ESR2—endometrium—breast cancer	0.000264	0.0168	CbGeAlD
Estramustine—ESR1—embryo—breast cancer	0.000247	0.0157	CbGeAlD
Estramustine—ESR2—uterus—breast cancer	0.000243	0.0155	CbGeAlD
Estramustine—ESR2—pituitary gland—breast cancer	0.000239	0.0152	CbGeAlD
Estramustine—ESR2—female reproductive system—breast cancer	0.000218	0.0139	CbGeAlD
Estramustine—ESR2—adrenal gland—breast cancer	0.000213	0.0136	CbGeAlD
Estramustine—ESR1—epithelium—breast cancer	0.000201	0.0128	CbGeAlD
Estramustine—ESR2—female gonad—breast cancer	0.000199	0.0127	CbGeAlD
Estramustine—MAP2—lymph node—breast cancer	0.000197	0.0126	CbGeAlD
Estramustine—Estradiol—GPER1—breast cancer	0.000196	0.112	CrCbGaD
Estramustine—ESR2—endocrine gland—breast cancer	0.000185	0.0118	CbGeAlD
Estramustine—ESR1—endometrium—breast cancer	0.000181	0.0115	CbGeAlD
Estramustine—ESR1—uterus—breast cancer	0.000166	0.0106	CbGeAlD
Estramustine—ESR1—pituitary gland—breast cancer	0.000163	0.0104	CbGeAlD
Estramustine—ESR1—adipose tissue—breast cancer	0.000163	0.0104	CbGeAlD
Estramustine—ESR1—female reproductive system—breast cancer	0.00015	0.00952	CbGeAlD
Estramustine—ESR1—adrenal gland—breast cancer	0.000146	0.00929	CbGeAlD
Estramustine—ESR1—female gonad—breast cancer	0.000136	0.00867	CbGeAlD
Estramustine—ESR2—lymph node—breast cancer	0.000128	0.00813	CbGeAlD
Estramustine—ESR1—endocrine gland—breast cancer	0.000127	0.00806	CbGeAlD
Estramustine—Estradiol—ESRRA—breast cancer	0.000126	0.072	CrCbGaD
Estramustine—ABCB1—embryo—breast cancer	9.74e-05	0.00621	CbGeAlD
Estramustine—ESR1—lymph node—breast cancer	8.75e-05	0.00557	CbGeAlD
Estramustine—CYP3A4—female reproductive system—breast cancer	8.34e-05	0.00531	CbGeAlD
Estramustine—ABCB1—epithelium—breast cancer	7.95e-05	0.00506	CbGeAlD
Estramustine—Estriol—ESR2—breast cancer	7.45e-05	0.0426	CrCbGaD
Estramustine—ABCB1—endometrium—breast cancer	7.13e-05	0.00454	CbGeAlD
Estramustine—CYP3A4—endocrine gland—breast cancer	7.06e-05	0.0045	CbGeAlD
Estramustine—Quinestrol—ESR1—breast cancer	6.94e-05	0.0397	CrCbGaD
Estramustine—Estriol—SHBG—breast cancer	6.79e-05	0.0388	CrCbGaD
Estramustine—ABCB1—uterus—breast cancer	6.57e-05	0.00418	CbGeAlD
Estramustine—ABCB1—pituitary gland—breast cancer	6.45e-05	0.00411	CbGeAlD
Estramustine—ABCB1—adipose tissue—breast cancer	6.43e-05	0.00409	CbGeAlD
Estramustine—ABCB1—female reproductive system—breast cancer	5.91e-05	0.00376	CbGeAlD
Estramustine—ABCB1—adrenal gland—breast cancer	5.76e-05	0.00367	CbGeAlD
Estramustine—Estropipate—ESR2—breast cancer	5.7e-05	0.0326	CrCbGaD
Estramustine—ABCB1—bone marrow—breast cancer	5.58e-05	0.00355	CbGeAlD
Estramustine—ABCB1—female gonad—breast cancer	5.37e-05	0.00342	CbGeAlD
Estramustine—Mestranol—ESR1—breast cancer	5.26e-05	0.0301	CrCbGaD
Estramustine—Estropipate—SHBG—breast cancer	5.2e-05	0.0297	CrCbGaD
Estramustine—Conjugated Estrogens—SLCO1B1—breast cancer	5.14e-05	0.0294	CrCbGaD
Estramustine—Estrone—SLCO1B1—breast cancer	5.12e-05	0.0293	CrCbGaD
Estramustine—ABCB1—endocrine gland—breast cancer	5e-05	0.00318	CbGeAlD
Estramustine—Estriol—ESR1—breast cancer	4.59e-05	0.0262	CrCbGaD
Estramustine—Conjugated Estrogens—ABCC1—breast cancer	4.24e-05	0.0242	CrCbGaD
Estramustine—Ethinyl Estradiol—ESR2—breast cancer	4.07e-05	0.0233	CrCbGaD
Estramustine—Estradiol—SLCO1B1—breast cancer	3.88e-05	0.0222	CrCbGaD
Estramustine—Conjugated Estrogens—COMT—breast cancer	3.81e-05	0.0218	CrCbGaD
Estramustine—Ethinyl Estradiol—SHBG—breast cancer	3.71e-05	0.0212	CrCbGaD
Estramustine—Conjugated Estrogens—ESR2—breast cancer	3.56e-05	0.0203	CrCbGaD
Estramustine—Estrone—ESR2—breast cancer	3.55e-05	0.0203	CrCbGaD
Estramustine—Estropipate—ESR1—breast cancer	3.51e-05	0.0201	CrCbGaD
Estramustine—ABCB1—lymph node—breast cancer	3.46e-05	0.0022	CbGeAlD
Estramustine—Estrone—SHBG—breast cancer	3.23e-05	0.0185	CrCbGaD
Estramustine—Estrone—CYP1B1—breast cancer	3.23e-05	0.0185	CrCbGaD
Estramustine—Decreased appetite—Vinorelbine—breast cancer	2.97e-05	0.00061	CcSEcCtD
Estramustine—Eye pain—Epirubicin—breast cancer	2.96e-05	0.000608	CcSEcCtD
Estramustine—Leukopenia—Fluorouracil—breast cancer	2.96e-05	0.000608	CcSEcCtD
Estramustine—Depression—Capecitabine—breast cancer	2.95e-05	0.000605	CcSEcCtD
Estramustine—Cardiac failure congestive—Epirubicin—breast cancer	2.95e-05	0.000605	CcSEcCtD
Estramustine—Chest pain—Mitoxantrone—breast cancer	2.94e-05	0.000603	CcSEcCtD
Estramustine—Anxiety—Mitoxantrone—breast cancer	2.93e-05	0.000601	CcSEcCtD
Estramustine—Acute coronary syndrome—Capecitabine—breast cancer	2.91e-05	0.000598	CcSEcCtD
Estramustine—Lethargy—Methotrexate—breast cancer	2.91e-05	0.000598	CcSEcCtD
Estramustine—Cerebrovascular accident—Methotrexate—breast cancer	2.91e-05	0.000598	CcSEcCtD
Estramustine—Myocardial infarction—Capecitabine—breast cancer	2.9e-05	0.000595	CcSEcCtD
Estramustine—Chest pain—Gemcitabine—breast cancer	2.86e-05	0.000588	CcSEcCtD
Estramustine—Alopecia—Paclitaxel—breast cancer	2.86e-05	0.000587	CcSEcCtD
Estramustine—Hot flush—Epirubicin—breast cancer	2.86e-05	0.000587	CcSEcCtD
Estramustine—Thrombophlebitis—Doxorubicin—breast cancer	2.86e-05	0.000587	CcSEcCtD
Estramustine—Vomiting—Chlorambucil—breast cancer	2.85e-05	0.000586	CcSEcCtD
Estramustine—Decreased appetite—Thiotepa—breast cancer	2.84e-05	0.000582	CcSEcCtD
Estramustine—Menopausal symptoms—Epirubicin—breast cancer	2.83e-05	0.000582	CcSEcCtD
Estramustine—Pruritus—Tamoxifen—breast cancer	2.82e-05	0.00058	CcSEcCtD
Estramustine—Oedema—Irinotecan—breast cancer	2.82e-05	0.000579	CcSEcCtD
Estramustine—Oedema—Mitoxantrone—breast cancer	2.82e-05	0.000579	CcSEcCtD
Estramustine—Chest pain—Fluorouracil—breast cancer	2.81e-05	0.000578	CcSEcCtD
Estramustine—Diarrhoea—Vinblastine—breast cancer	2.81e-05	0.000578	CcSEcCtD
Estramustine—Flatulence—Paclitaxel—breast cancer	2.77e-05	0.00057	CcSEcCtD
Estramustine—Pruritus—Melphalan—breast cancer	2.77e-05	0.000568	CcSEcCtD
Estramustine—Thrombocytopenia—Irinotecan—breast cancer	2.76e-05	0.000566	CcSEcCtD
Estramustine—Thrombocytopenia—Mitoxantrone—breast cancer	2.76e-05	0.000566	CcSEcCtD
Estramustine—Oedema—Gemcitabine—breast cancer	2.74e-05	0.000564	CcSEcCtD
Estramustine—Eye pain—Doxorubicin—breast cancer	2.74e-05	0.000563	CcSEcCtD
Estramustine—Diarrhoea—Tamoxifen—breast cancer	2.73e-05	0.000561	CcSEcCtD
Estramustine—Cerebrovascular accident—Epirubicin—breast cancer	2.73e-05	0.00056	CcSEcCtD
Estramustine—Lethargy—Epirubicin—breast cancer	2.73e-05	0.00056	CcSEcCtD
Estramustine—Cardiac failure congestive—Doxorubicin—breast cancer	2.73e-05	0.00056	CcSEcCtD
Estramustine—Muscle spasms—Paclitaxel—breast cancer	2.71e-05	0.000556	CcSEcCtD
Estramustine—Mood swings—Methotrexate—breast cancer	2.71e-05	0.000556	CcSEcCtD
Estramustine—Pruritus—Goserelin—breast cancer	2.7e-05	0.000554	CcSEcCtD
Estramustine—Oedema—Fluorouracil—breast cancer	2.7e-05	0.000554	CcSEcCtD
Estramustine—Estradiol—ESR2—breast cancer	2.69e-05	0.0154	CrCbGaD
Estramustine—Thrombocytopenia—Gemcitabine—breast cancer	2.69e-05	0.000552	CcSEcCtD
Estramustine—Anorexia—Irinotecan—breast cancer	2.69e-05	0.000551	CcSEcCtD
Estramustine—Anorexia—Mitoxantrone—breast cancer	2.69e-05	0.000551	CcSEcCtD
Estramustine—Diarrhoea—Melphalan—breast cancer	2.67e-05	0.000549	CcSEcCtD
Estramustine—Gastrointestinal haemorrhage—Epirubicin—breast cancer	2.67e-05	0.000549	CcSEcCtD
Estramustine—Nausea—Chlorambucil—breast cancer	2.66e-05	0.000547	CcSEcCtD
Estramustine—Hot flush—Doxorubicin—breast cancer	2.64e-05	0.000543	CcSEcCtD
Estramustine—Thrombocytopenia—Fluorouracil—breast cancer	2.64e-05	0.000543	CcSEcCtD
Estramustine—Liver function test abnormal—Methotrexate—breast cancer	2.64e-05	0.000541	CcSEcCtD
Estramustine—Affect lability—Epirubicin—breast cancer	2.63e-05	0.00054	CcSEcCtD
Estramustine—Menopausal symptoms—Doxorubicin—breast cancer	2.62e-05	0.000538	CcSEcCtD
Estramustine—Anorexia—Gemcitabine—breast cancer	2.62e-05	0.000537	CcSEcCtD
Estramustine—Vomiting—Vinblastine—breast cancer	2.61e-05	0.000537	CcSEcCtD
Estramustine—Diarrhoea—Goserelin—breast cancer	2.61e-05	0.000536	CcSEcCtD
Estramustine—Headache—Vinblastine—breast cancer	2.57e-05	0.000529	CcSEcCtD
Estramustine—Anorexia—Fluorouracil—breast cancer	2.57e-05	0.000528	CcSEcCtD
Estramustine—Insomnia—Irinotecan—breast cancer	2.55e-05	0.000523	CcSEcCtD
Estramustine—Flushing—Docetaxel—breast cancer	2.54e-05	0.000522	CcSEcCtD
Estramustine—Cardiac arrest—Epirubicin—breast cancer	2.54e-05	0.000522	CcSEcCtD
Estramustine—Vomiting—Tamoxifen—breast cancer	2.54e-05	0.000521	CcSEcCtD
Estramustine—Mood swings—Epirubicin—breast cancer	2.53e-05	0.00052	CcSEcCtD
Estramustine—Cerebrovascular accident—Doxorubicin—breast cancer	2.52e-05	0.000518	CcSEcCtD
Estramustine—Lethargy—Doxorubicin—breast cancer	2.52e-05	0.000518	CcSEcCtD
Estramustine—Leukopenia—Paclitaxel—breast cancer	2.52e-05	0.000517	CcSEcCtD
Estramustine—Rash—Tamoxifen—breast cancer	2.52e-05	0.000517	CcSEcCtD
Estramustine—Dermatitis—Tamoxifen—breast cancer	2.52e-05	0.000517	CcSEcCtD
Estramustine—Dyspnoea—Mitoxantrone—breast cancer	2.51e-05	0.000516	CcSEcCtD
Estramustine—Dyspnoea—Irinotecan—breast cancer	2.51e-05	0.000516	CcSEcCtD
Estramustine—Ethinyl Estradiol—ESR1—breast cancer	2.51e-05	0.0143	CrCbGaD
Estramustine—Headache—Tamoxifen—breast cancer	2.5e-05	0.000514	CcSEcCtD
Estramustine—Vomiting—Melphalan—breast cancer	2.49e-05	0.000511	CcSEcCtD
Estramustine—Insomnia—Gemcitabine—breast cancer	2.48e-05	0.00051	CcSEcCtD
Estramustine—Tinnitus—Capecitabine—breast cancer	2.47e-05	0.000508	CcSEcCtD
Estramustine—Gastrointestinal haemorrhage—Doxorubicin—breast cancer	2.47e-05	0.000508	CcSEcCtD
Estramustine—Liver function test abnormal—Epirubicin—breast cancer	2.47e-05	0.000507	CcSEcCtD
Estramustine—Rash—Melphalan—breast cancer	2.47e-05	0.000506	CcSEcCtD
Estramustine—Flushing—Capecitabine—breast cancer	2.46e-05	0.000506	CcSEcCtD
Estramustine—Dermatitis—Melphalan—breast cancer	2.46e-05	0.000506	CcSEcCtD
Estramustine—Estradiol—SHBG—breast cancer	2.45e-05	0.014	CrCbGaD
Estramustine—Estradiol—CYP1B1—breast cancer	2.45e-05	0.014	CrCbGaD
Estramustine—Dry skin—Epirubicin—breast cancer	2.45e-05	0.000503	CcSEcCtD
Estramustine—Decreased appetite—Mitoxantrone—breast cancer	2.45e-05	0.000503	CcSEcCtD
Estramustine—Decreased appetite—Irinotecan—breast cancer	2.45e-05	0.000503	CcSEcCtD
Estramustine—Dyspnoea—Gemcitabine—breast cancer	2.45e-05	0.000502	CcSEcCtD
Estramustine—Nausea—Vinblastine—breast cancer	2.44e-05	0.000501	CcSEcCtD
Estramustine—Insomnia—Fluorouracil—breast cancer	2.44e-05	0.000501	CcSEcCtD
Estramustine—Affect lability—Doxorubicin—breast cancer	2.43e-05	0.0005	CcSEcCtD
Estramustine—Vomiting—Goserelin—breast cancer	2.42e-05	0.000498	CcSEcCtD
Estramustine—Alopecia—Docetaxel—breast cancer	2.42e-05	0.000497	CcSEcCtD
Estramustine—Pruritus—Vinorelbine—breast cancer	2.42e-05	0.000496	CcSEcCtD
Estramustine—Dyspnoea—Fluorouracil—breast cancer	2.41e-05	0.000494	CcSEcCtD
Estramustine—Rash—Goserelin—breast cancer	2.4e-05	0.000494	CcSEcCtD
Estramustine—Dermatitis—Goserelin—breast cancer	2.4e-05	0.000493	CcSEcCtD
Estramustine—Chest pain—Paclitaxel—breast cancer	2.4e-05	0.000492	CcSEcCtD
Estramustine—Headache—Goserelin—breast cancer	2.39e-05	0.000491	CcSEcCtD
Estramustine—Anxiety—Paclitaxel—breast cancer	2.39e-05	0.00049	CcSEcCtD
Estramustine—Decreased appetite—Gemcitabine—breast cancer	2.39e-05	0.00049	CcSEcCtD
Estramustine—Nausea—Tamoxifen—breast cancer	2.37e-05	0.000487	CcSEcCtD
Estramustine—Abdominal discomfort—Methotrexate—breast cancer	2.37e-05	0.000486	CcSEcCtD
Estramustine—Cardiac arrest—Doxorubicin—breast cancer	2.35e-05	0.000483	CcSEcCtD
Estramustine—Decreased appetite—Fluorouracil—breast cancer	2.35e-05	0.000482	CcSEcCtD
Estramustine—Alopecia—Capecitabine—breast cancer	2.34e-05	0.000482	CcSEcCtD
Estramustine—Pancytopenia—Methotrexate—breast cancer	2.34e-05	0.000481	CcSEcCtD
Estramustine—Mood swings—Doxorubicin—breast cancer	2.34e-05	0.000481	CcSEcCtD
Estramustine—Diarrhoea—Vinorelbine—breast cancer	2.34e-05	0.00048	CcSEcCtD
Estramustine—Nausea—Melphalan—breast cancer	2.32e-05	0.000477	CcSEcCtD
Estramustine—Pruritus—Thiotepa—breast cancer	2.31e-05	0.000474	CcSEcCtD
Estramustine—Oedema—Paclitaxel—breast cancer	2.3e-05	0.000472	CcSEcCtD
Estramustine—Muscle spasms—Docetaxel—breast cancer	2.29e-05	0.000471	CcSEcCtD
Estramustine—Liver function test abnormal—Doxorubicin—breast cancer	2.28e-05	0.000469	CcSEcCtD
Estramustine—Flatulence—Capecitabine—breast cancer	2.28e-05	0.000467	CcSEcCtD
Estramustine—Erectile dysfunction—Methotrexate—breast cancer	2.27e-05	0.000467	CcSEcCtD
Estramustine—Dry skin—Doxorubicin—breast cancer	2.27e-05	0.000465	CcSEcCtD
Estramustine—Nausea—Goserelin—breast cancer	2.27e-05	0.000465	CcSEcCtD
Estramustine—Thrombocytopenia—Paclitaxel—breast cancer	2.25e-05	0.000462	CcSEcCtD
Estramustine—Conjugated Estrogens—ABCG2—breast cancer	2.24e-05	0.0128	CrCbGaD
Estramustine—Diarrhoea—Thiotepa—breast cancer	2.23e-05	0.000458	CcSEcCtD
Estramustine—Estrone—ABCG2—breast cancer	2.23e-05	0.0127	CrCbGaD
Estramustine—Muscle spasms—Capecitabine—breast cancer	2.22e-05	0.000456	CcSEcCtD
Estramustine—Depression—Methotrexate—breast cancer	2.19e-05	0.000451	CcSEcCtD
Estramustine—Pancytopenia—Epirubicin—breast cancer	2.19e-05	0.00045	CcSEcCtD
Estramustine—Conjugated Estrogens—ESR1—breast cancer	2.19e-05	0.0125	CrCbGaD
Estramustine—Anorexia—Paclitaxel—breast cancer	2.19e-05	0.00045	CcSEcCtD
Estramustine—Estrone—ESR1—breast cancer	2.18e-05	0.0125	CrCbGaD
Estramustine—Vomiting—Vinorelbine—breast cancer	2.17e-05	0.000446	CcSEcCtD
Estramustine—Rash—Vinorelbine—breast cancer	2.15e-05	0.000442	CcSEcCtD
Estramustine—Dermatitis—Vinorelbine—breast cancer	2.15e-05	0.000442	CcSEcCtD
Estramustine—Estradiol—AR—breast cancer	2.15e-05	0.0123	CrCbGaD
Estramustine—Headache—Vinorelbine—breast cancer	2.14e-05	0.000439	CcSEcCtD
Estramustine—Leukopenia—Docetaxel—breast cancer	2.14e-05	0.000439	CcSEcCtD
Estramustine—Insomnia—Paclitaxel—breast cancer	2.08e-05	0.000427	CcSEcCtD
Estramustine—Vomiting—Thiotepa—breast cancer	2.07e-05	0.000426	CcSEcCtD
Estramustine—Leukopenia—Capecitabine—breast cancer	2.07e-05	0.000425	CcSEcCtD
Estramustine—Rash—Thiotepa—breast cancer	2.06e-05	0.000422	CcSEcCtD
Estramustine—Dermatitis—Thiotepa—breast cancer	2.05e-05	0.000422	CcSEcCtD
Estramustine—Dyspnoea—Paclitaxel—breast cancer	2.05e-05	0.000421	CcSEcCtD
Estramustine—Headache—Thiotepa—breast cancer	2.04e-05	0.00042	CcSEcCtD
Estramustine—Chest pain—Docetaxel—breast cancer	2.03e-05	0.000417	CcSEcCtD
Estramustine—Pancytopenia—Doxorubicin—breast cancer	2.03e-05	0.000417	CcSEcCtD
Estramustine—Nausea—Vinorelbine—breast cancer	2.03e-05	0.000417	CcSEcCtD
Estramustine—Decreased appetite—Paclitaxel—breast cancer	2e-05	0.00041	CcSEcCtD
Estramustine—Chest pain—Capecitabine—breast cancer	1.97e-05	0.000404	CcSEcCtD
Estramustine—Testosterone—SHBG—breast cancer	1.97e-05	0.0112	CrCbGaD
Estramustine—Testosterone—CYP1B1—breast cancer	1.97e-05	0.0112	CrCbGaD
Estramustine—Anxiety—Capecitabine—breast cancer	1.96e-05	0.000403	CcSEcCtD
Estramustine—Estriol—ABCB1—breast cancer	1.95e-05	0.0111	CrCbGaD
Estramustine—Oedema—Docetaxel—breast cancer	1.95e-05	0.0004	CcSEcCtD
Estramustine—Pruritus—Gemcitabine—breast cancer	1.94e-05	0.000399	CcSEcCtD
Estramustine—Nausea—Thiotepa—breast cancer	1.94e-05	0.000398	CcSEcCtD
Estramustine—Diarrhoea—Mitoxantrone—breast cancer	1.93e-05	0.000396	CcSEcCtD
Estramustine—Diarrhoea—Irinotecan—breast cancer	1.93e-05	0.000396	CcSEcCtD
Estramustine—Pruritus—Fluorouracil—breast cancer	1.91e-05	0.000392	CcSEcCtD
Estramustine—Thrombocytopenia—Docetaxel—breast cancer	1.91e-05	0.000392	CcSEcCtD
Estramustine—Oedema—Capecitabine—breast cancer	1.89e-05	0.000387	CcSEcCtD
Estramustine—Diarrhoea—Gemcitabine—breast cancer	1.88e-05	0.000386	CcSEcCtD
Estramustine—Anorexia—Docetaxel—breast cancer	1.86e-05	0.000381	CcSEcCtD
Estramustine—Diarrhoea—Fluorouracil—breast cancer	1.85e-05	0.000379	CcSEcCtD
Estramustine—Thrombocytopenia—Capecitabine—breast cancer	1.85e-05	0.000379	CcSEcCtD
Estramustine—Tinnitus—Methotrexate—breast cancer	1.84e-05	0.000378	CcSEcCtD
Estramustine—Anorexia—Capecitabine—breast cancer	1.8e-05	0.000369	CcSEcCtD
Estramustine—Vomiting—Mitoxantrone—breast cancer	1.79e-05	0.000368	CcSEcCtD
Estramustine—Vomiting—Irinotecan—breast cancer	1.79e-05	0.000368	CcSEcCtD
Estramustine—Estropipate—CYP3A4—breast cancer	1.79e-05	0.0102	CrCbGaD
Estramustine—Rash—Irinotecan—breast cancer	1.78e-05	0.000365	CcSEcCtD
Estramustine—Rash—Mitoxantrone—breast cancer	1.78e-05	0.000365	CcSEcCtD
Estramustine—Dermatitis—Mitoxantrone—breast cancer	1.77e-05	0.000364	CcSEcCtD
Estramustine—Dermatitis—Irinotecan—breast cancer	1.77e-05	0.000364	CcSEcCtD
Estramustine—Headache—Irinotecan—breast cancer	1.76e-05	0.000362	CcSEcCtD
Estramustine—Headache—Mitoxantrone—breast cancer	1.76e-05	0.000362	CcSEcCtD
Estramustine—Insomnia—Docetaxel—breast cancer	1.76e-05	0.000362	CcSEcCtD
Estramustine—Estrone—CYP1A1—breast cancer	1.75e-05	0.00998	CrCbGaD
Estramustine—Alopecia—Methotrexate—breast cancer	1.75e-05	0.000359	CcSEcCtD
Estramustine—Vomiting—Gemcitabine—breast cancer	1.74e-05	0.000358	CcSEcCtD
Estramustine—Dyspnoea—Docetaxel—breast cancer	1.74e-05	0.000357	CcSEcCtD
Estramustine—Rash—Gemcitabine—breast cancer	1.73e-05	0.000355	CcSEcCtD
Estramustine—Dermatitis—Gemcitabine—breast cancer	1.73e-05	0.000355	CcSEcCtD
Estramustine—Testosterone—AR—breast cancer	1.72e-05	0.00985	CrCbGaD
Estramustine—Tinnitus—Epirubicin—breast cancer	1.72e-05	0.000354	CcSEcCtD
Estramustine—Headache—Gemcitabine—breast cancer	1.72e-05	0.000353	CcSEcCtD
Estramustine—Flushing—Epirubicin—breast cancer	1.72e-05	0.000352	CcSEcCtD
Estramustine—Vomiting—Fluorouracil—breast cancer	1.72e-05	0.000352	CcSEcCtD
Estramustine—Insomnia—Capecitabine—breast cancer	1.71e-05	0.00035	CcSEcCtD
Estramustine—Rash—Fluorouracil—breast cancer	1.7e-05	0.000349	CcSEcCtD
Estramustine—Dermatitis—Fluorouracil—breast cancer	1.7e-05	0.000349	CcSEcCtD
Estramustine—Decreased appetite—Docetaxel—breast cancer	1.69e-05	0.000348	CcSEcCtD
Estramustine—Headache—Fluorouracil—breast cancer	1.69e-05	0.000347	CcSEcCtD
Estramustine—Estradiol—ABCG2—breast cancer	1.69e-05	0.00966	CrCbGaD
Estramustine—Dyspnoea—Capecitabine—breast cancer	1.68e-05	0.000345	CcSEcCtD
Estramustine—Nausea—Mitoxantrone—breast cancer	1.67e-05	0.000344	CcSEcCtD
Estramustine—Nausea—Irinotecan—breast cancer	1.67e-05	0.000344	CcSEcCtD
Estramustine—Estradiol—ESR1—breast cancer	1.66e-05	0.00946	CrCbGaD
Estramustine—Decreased appetite—Capecitabine—breast cancer	1.64e-05	0.000337	CcSEcCtD
Estramustine—Alopecia—Epirubicin—breast cancer	1.63e-05	0.000336	CcSEcCtD
Estramustine—Nausea—Gemcitabine—breast cancer	1.63e-05	0.000335	CcSEcCtD
Estramustine—Pruritus—Paclitaxel—breast cancer	1.63e-05	0.000334	CcSEcCtD
Estramustine—Nausea—Fluorouracil—breast cancer	1.6e-05	0.000329	CcSEcCtD
Estramustine—Tinnitus—Doxorubicin—breast cancer	1.59e-05	0.000328	CcSEcCtD
Estramustine—Flushing—Doxorubicin—breast cancer	1.59e-05	0.000326	CcSEcCtD
Estramustine—Flatulence—Epirubicin—breast cancer	1.59e-05	0.000326	CcSEcCtD
Estramustine—Diarrhoea—Paclitaxel—breast cancer	1.57e-05	0.000323	CcSEcCtD
Estramustine—Estropipate—ALB—breast cancer	1.56e-05	0.00893	CrCbGaD
Estramustine—Muscle spasms—Epirubicin—breast cancer	1.55e-05	0.000318	CcSEcCtD
Estramustine—Leukopenia—Methotrexate—breast cancer	1.54e-05	0.000316	CcSEcCtD
Estramustine—Alopecia—Doxorubicin—breast cancer	1.51e-05	0.00031	CcSEcCtD
Estramustine—Flatulence—Doxorubicin—breast cancer	1.47e-05	0.000301	CcSEcCtD
Estramustine—Chest pain—Methotrexate—breast cancer	1.46e-05	0.000301	CcSEcCtD
Estramustine—Vomiting—Paclitaxel—breast cancer	1.46e-05	0.0003	CcSEcCtD
Estramustine—Rash—Paclitaxel—breast cancer	1.45e-05	0.000297	CcSEcCtD
Estramustine—Dermatitis—Paclitaxel—breast cancer	1.45e-05	0.000297	CcSEcCtD
Estramustine—Testosterone—CYP19A1—breast cancer	1.44e-05	0.00825	CrCbGaD
Estramustine—Leukopenia—Epirubicin—breast cancer	1.44e-05	0.000296	CcSEcCtD
Estramustine—Headache—Paclitaxel—breast cancer	1.44e-05	0.000296	CcSEcCtD
Estramustine—Muscle spasms—Doxorubicin—breast cancer	1.43e-05	0.000294	CcSEcCtD
Estramustine—Pruritus—Docetaxel—breast cancer	1.38e-05	0.000283	CcSEcCtD
Estramustine—Thrombocytopenia—Methotrexate—breast cancer	1.37e-05	0.000282	CcSEcCtD
Estramustine—Chest pain—Epirubicin—breast cancer	1.37e-05	0.000281	CcSEcCtD
Estramustine—Anxiety—Epirubicin—breast cancer	1.37e-05	0.00028	CcSEcCtD
Estramustine—Nausea—Paclitaxel—breast cancer	1.36e-05	0.00028	CcSEcCtD
Estramustine—Testosterone—ABCG2—breast cancer	1.36e-05	0.00775	CrCbGaD
Estramustine—Anorexia—Methotrexate—breast cancer	1.34e-05	0.000275	CcSEcCtD
Estramustine—Pruritus—Capecitabine—breast cancer	1.33e-05	0.000274	CcSEcCtD
Estramustine—Leukopenia—Doxorubicin—breast cancer	1.33e-05	0.000274	CcSEcCtD
Estramustine—Diarrhoea—Docetaxel—breast cancer	1.33e-05	0.000274	CcSEcCtD
Estramustine—Estradiol—CYP1A1—breast cancer	1.32e-05	0.00756	CrCbGaD
Estramustine—Oedema—Epirubicin—breast cancer	1.31e-05	0.00027	CcSEcCtD
Estramustine—Diarrhoea—Capecitabine—breast cancer	1.29e-05	0.000265	CcSEcCtD
Estramustine—Thrombocytopenia—Epirubicin—breast cancer	1.29e-05	0.000264	CcSEcCtD
Estramustine—Ethinyl Estradiol—CYP3A4—breast cancer	1.28e-05	0.00731	CrCbGaD
Estramustine—Insomnia—Methotrexate—breast cancer	1.27e-05	0.000261	CcSEcCtD
Estramustine—Chest pain—Doxorubicin—breast cancer	1.27e-05	0.00026	CcSEcCtD
Estramustine—Anxiety—Doxorubicin—breast cancer	1.26e-05	0.000259	CcSEcCtD
Estramustine—Anorexia—Epirubicin—breast cancer	1.25e-05	0.000257	CcSEcCtD
Estramustine—Dyspnoea—Methotrexate—breast cancer	1.25e-05	0.000257	CcSEcCtD
Estramustine—Vomiting—Docetaxel—breast cancer	1.24e-05	0.000254	CcSEcCtD
Estramustine—Rash—Docetaxel—breast cancer	1.23e-05	0.000252	CcSEcCtD
Estramustine—Dermatitis—Docetaxel—breast cancer	1.23e-05	0.000252	CcSEcCtD
Estramustine—Decreased appetite—Methotrexate—breast cancer	1.22e-05	0.000251	CcSEcCtD
Estramustine—Headache—Docetaxel—breast cancer	1.22e-05	0.000251	CcSEcCtD
Estramustine—Oedema—Doxorubicin—breast cancer	1.22e-05	0.00025	CcSEcCtD
Estramustine—Vomiting—Capecitabine—breast cancer	1.2e-05	0.000246	CcSEcCtD
Estramustine—Thrombocytopenia—Doxorubicin—breast cancer	1.19e-05	0.000244	CcSEcCtD
Estramustine—Rash—Capecitabine—breast cancer	1.19e-05	0.000244	CcSEcCtD
Estramustine—Insomnia—Epirubicin—breast cancer	1.19e-05	0.000244	CcSEcCtD
Estramustine—Dermatitis—Capecitabine—breast cancer	1.19e-05	0.000244	CcSEcCtD
Estramustine—Headache—Capecitabine—breast cancer	1.18e-05	0.000243	CcSEcCtD
Estramustine—Dyspnoea—Epirubicin—breast cancer	1.17e-05	0.00024	CcSEcCtD
Estramustine—Anorexia—Doxorubicin—breast cancer	1.16e-05	0.000238	CcSEcCtD
Estramustine—Nausea—Docetaxel—breast cancer	1.16e-05	0.000238	CcSEcCtD
Estramustine—Decreased appetite—Epirubicin—breast cancer	1.14e-05	0.000234	CcSEcCtD
Estramustine—Nausea—Capecitabine—breast cancer	1.12e-05	0.00023	CcSEcCtD
Estramustine—Conjugated Estrogens—CYP3A4—breast cancer	1.12e-05	0.00639	CrCbGaD
Estramustine—Estrone—CYP3A4—breast cancer	1.11e-05	0.00637	CrCbGaD
Estramustine—Insomnia—Doxorubicin—breast cancer	1.1e-05	0.000226	CcSEcCtD
Estramustine—Dyspnoea—Doxorubicin—breast cancer	1.08e-05	0.000223	CcSEcCtD
Estramustine—Ethinyl Estradiol—ABCB1—breast cancer	1.07e-05	0.00609	CrCbGaD
Estramustine—Testosterone—CYP1A1—breast cancer	1.06e-05	0.00607	CrCbGaD
Estramustine—Decreased appetite—Doxorubicin—breast cancer	1.06e-05	0.000217	CcSEcCtD
Estramustine—Pruritus—Methotrexate—breast cancer	9.93e-06	0.000204	CcSEcCtD
Estramustine—Estrone—ALB—breast cancer	9.72e-06	0.00556	CrCbGaD
Estramustine—Diarrhoea—Methotrexate—breast cancer	9.6e-06	0.000197	CcSEcCtD
Estramustine—Conjugated Estrogens—ABCB1—breast cancer	9.31e-06	0.00532	CrCbGaD
Estramustine—Pruritus—Epirubicin—breast cancer	9.29e-06	0.000191	CcSEcCtD
Estramustine—Estrone—ABCB1—breast cancer	9.28e-06	0.0053	CrCbGaD
Estramustine—Diarrhoea—Epirubicin—breast cancer	8.99e-06	0.000185	CcSEcCtD
Estramustine—Vomiting—Methotrexate—breast cancer	8.92e-06	0.000183	CcSEcCtD
Estramustine—Rash—Methotrexate—breast cancer	8.85e-06	0.000182	CcSEcCtD
Estramustine—Dermatitis—Methotrexate—breast cancer	8.84e-06	0.000182	CcSEcCtD
Estramustine—Headache—Methotrexate—breast cancer	8.79e-06	0.000181	CcSEcCtD
Estramustine—Pruritus—Doxorubicin—breast cancer	8.6e-06	0.000177	CcSEcCtD
Estramustine—Estradiol—CYP3A4—breast cancer	8.45e-06	0.00483	CrCbGaD
Estramustine—Vomiting—Epirubicin—breast cancer	8.35e-06	0.000172	CcSEcCtD
Estramustine—Nausea—Methotrexate—breast cancer	8.34e-06	0.000171	CcSEcCtD
Estramustine—Diarrhoea—Doxorubicin—breast cancer	8.32e-06	0.000171	CcSEcCtD
Estramustine—Rash—Epirubicin—breast cancer	8.28e-06	0.00017	CcSEcCtD
Estramustine—Dermatitis—Epirubicin—breast cancer	8.27e-06	0.00017	CcSEcCtD
Estramustine—Headache—Epirubicin—breast cancer	8.23e-06	0.000169	CcSEcCtD
Estramustine—Nausea—Epirubicin—breast cancer	7.8e-06	0.00016	CcSEcCtD
Estramustine—Vomiting—Doxorubicin—breast cancer	7.73e-06	0.000159	CcSEcCtD
Estramustine—Rash—Doxorubicin—breast cancer	7.66e-06	0.000157	CcSEcCtD
Estramustine—Dermatitis—Doxorubicin—breast cancer	7.66e-06	0.000157	CcSEcCtD
Estramustine—Headache—Doxorubicin—breast cancer	7.61e-06	0.000156	CcSEcCtD
Estramustine—Estradiol—ALB—breast cancer	7.37e-06	0.00421	CrCbGaD
Estramustine—Nausea—Doxorubicin—breast cancer	7.22e-06	0.000148	CcSEcCtD
Estramustine—Estradiol—ABCB1—breast cancer	7.03e-06	0.00402	CrCbGaD
Estramustine—Testosterone—CYP3A4—breast cancer	6.78e-06	0.00387	CrCbGaD
Estramustine—Testosterone—ALB—breast cancer	5.91e-06	0.00338	CrCbGaD
Estramustine—Testosterone—ABCB1—breast cancer	5.64e-06	0.00322	CrCbGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	2.1e-06	6.53e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—FLT1—breast cancer	2.05e-06	6.38e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—FGF3—breast cancer	2.04e-06	6.35e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—SQSTM1—breast cancer	2.04e-06	6.35e-05	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	2.04e-06	6.35e-05	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	2.04e-06	6.33e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GSTA4—breast cancer	2.02e-06	6.29e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CA9—breast cancer	2.02e-06	6.29e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—JAG1—breast cancer	2.02e-06	6.27e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NOTCH3—breast cancer	2.01e-06	6.25e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PARP1—breast cancer	2.01e-06	6.25e-05	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	2e-06	6.21e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CALCA—breast cancer	1.98e-06	6.17e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GSTA2—breast cancer	1.97e-06	6.13e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GPX2—breast cancer	1.97e-06	6.13e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—RPS6—breast cancer	1.96e-06	6.1e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GPX4—breast cancer	1.95e-06	6.06e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—SULT1A1—breast cancer	1.95e-06	6.06e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—FGF4—breast cancer	1.94e-06	6.05e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CXCL12—breast cancer	1.94e-06	6.03e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CXCR4—breast cancer	1.94e-06	6.03e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CDA—breast cancer	1.93e-06	6.02e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—SHMT1—breast cancer	1.93e-06	6.02e-05	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—MYC—breast cancer	1.92e-06	5.96e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—IDH1—breast cancer	1.9e-06	5.92e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GSTA1—breast cancer	1.9e-06	5.92e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PAK1—breast cancer	1.9e-06	5.92e-05	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	1.9e-06	5.91e-05	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	1.89e-06	5.87e-05	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—MAPK3—breast cancer	1.88e-06	5.85e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—NAT2—breast cancer	1.88e-06	5.85e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TCF7L2—breast cancer	1.87e-06	5.81e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—SLC2A5—breast cancer	1.86e-06	5.79e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—SLCO1B1—breast cancer	1.86e-06	5.79e-05	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—MYC—breast cancer	1.83e-06	5.69e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NOTCH2—breast cancer	1.8e-06	5.6e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—HSP90AA1—breast cancer	1.8e-06	5.6e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—APRT—breast cancer	1.8e-06	5.59e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PRL—breast cancer	1.75e-06	5.45e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—AGTR1—breast cancer	1.75e-06	5.45e-05	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	1.73e-06	5.39e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—STK11—breast cancer	1.73e-06	5.37e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—ADAM10—breast cancer	1.73e-06	5.37e-05	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—NOTCH1—breast cancer	1.71e-06	5.33e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PLG—breast cancer	1.71e-06	5.31e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ANGPTL4—breast cancer	1.69e-06	5.26e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ESRRA—breast cancer	1.69e-06	5.26e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—FGF10—breast cancer	1.68e-06	5.23e-05	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	1.68e-06	5.21e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—MED12—breast cancer	1.65e-06	5.13e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—DPYD—breast cancer	1.65e-06	5.13e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—ALDOA—breast cancer	1.62e-06	5.05e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PDGFA—breast cancer	1.62e-06	5.04e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GPI—breast cancer	1.6e-06	4.99e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—HADHB—breast cancer	1.6e-06	4.99e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TGFBR2—breast cancer	1.6e-06	4.97e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—NCOA3—breast cancer	1.58e-06	4.9e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—ITPR1—breast cancer	1.57e-06	4.89e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—SLC2A2—breast cancer	1.56e-06	4.87e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—ERBB4—breast cancer	1.56e-06	4.86e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—MMP3—breast cancer	1.56e-06	4.86e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—STAT5A—breast cancer	1.56e-06	4.86e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CPT1A—breast cancer	1.53e-06	4.77e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—MTR—breast cancer	1.53e-06	4.77e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—ABCG2—breast cancer	1.53e-06	4.77e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ALDH7A1—breast cancer	1.53e-06	4.76e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ALDH1A1—breast cancer	1.53e-06	4.76e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—SMAD4—breast cancer	1.51e-06	4.7e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—HPGDS—breast cancer	1.5e-06	4.68e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—IGF1R—breast cancer	1.5e-06	4.68e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—HBA1—breast cancer	1.49e-06	4.65e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—HES1—breast cancer	1.48e-06	4.59e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NCOR1—breast cancer	1.47e-06	4.57e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PLA2G4A—breast cancer	1.47e-06	4.57e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ADSL—breast cancer	1.47e-06	4.56e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—UMPS—breast cancer	1.47e-06	4.56e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—FHL2—breast cancer	1.47e-06	4.56e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—NME1—breast cancer	1.47e-06	4.56e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PHGDH—breast cancer	1.47e-06	4.56e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—ACHE—breast cancer	1.46e-06	4.54e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GSTT1—breast cancer	1.46e-06	4.54e-05	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—SERPINE1—breast cancer	1.46e-06	4.54e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—FGF1—breast cancer	1.45e-06	4.52e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CSF2—breast cancer	1.45e-06	4.52e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NRG1—breast cancer	1.44e-06	4.48e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—BRIP1—breast cancer	1.44e-06	4.47e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—HPSE—breast cancer	1.44e-06	4.47e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—LDHB—breast cancer	1.44e-06	4.47e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—H2AFX—breast cancer	1.43e-06	4.45e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—E2F1—breast cancer	1.42e-06	4.42e-05	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	1.41e-06	4.4e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CYP17A1—breast cancer	1.38e-06	4.29e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PTGS1—breast cancer	1.37e-06	4.25e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—ENO1—breast cancer	1.37e-06	4.25e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—SPP1—breast cancer	1.36e-06	4.25e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GSTA3—breast cancer	1.36e-06	4.24e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ABCC1—breast cancer	1.36e-06	4.24e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—HMMR—breast cancer	1.36e-06	4.24e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—ERBB3—breast cancer	1.35e-06	4.2e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—FGFR2—breast cancer	1.35e-06	4.19e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CYP2D6—breast cancer	1.34e-06	4.17e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PPARGC1B—breast cancer	1.32e-06	4.11e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—NCOA2—breast cancer	1.32e-06	4.09e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TERT—breast cancer	1.29e-06	4.03e-05	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	1.28e-06	3.98e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—FASN—breast cancer	1.28e-06	3.97e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—BCHE—breast cancer	1.27e-06	3.95e-05	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—AKT1—breast cancer	1.27e-06	3.95e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—FGFR1—breast cancer	1.26e-06	3.91e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—SLC5A5—breast cancer	1.25e-06	3.9e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CA9—breast cancer	1.25e-06	3.88e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GSTA4—breast cancer	1.25e-06	3.88e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—HIF1A—breast cancer	1.24e-06	3.85e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GSTA2—breast cancer	1.21e-06	3.78e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GPX2—breast cancer	1.21e-06	3.78e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—NQO1—breast cancer	1.21e-06	3.77e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—SLC2A1—breast cancer	1.21e-06	3.77e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—LEP—breast cancer	1.21e-06	3.76e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GPX4—breast cancer	1.2e-06	3.73e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—SULT1A1—breast cancer	1.2e-06	3.73e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CAV1—breast cancer	1.2e-06	3.72e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—KDR—breast cancer	1.18e-06	3.68e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CYP3A4—breast cancer	1.18e-06	3.68e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—IDH1—breast cancer	1.17e-06	3.65e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GSTA1—breast cancer	1.17e-06	3.65e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CYP1B1—breast cancer	1.16e-06	3.61e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—NAT2—breast cancer	1.16e-06	3.61e-05	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	1.16e-06	3.6e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—HSP90AA1—breast cancer	1.14e-06	3.55e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—FN1—breast cancer	1.14e-06	3.54e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NFKBIA—breast cancer	1.13e-06	3.5e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NOTCH1—breast cancer	1.11e-06	3.47e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—NCOA1—breast cancer	1.11e-06	3.45e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—STK11—breast cancer	1.09e-06	3.4e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CYP19A1—breast cancer	1.09e-06	3.4e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PIK3CG—breast cancer	1.09e-06	3.39e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—APC—breast cancer	1.09e-06	3.39e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—KIT—breast cancer	1.09e-06	3.39e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—EGF—breast cancer	1.08e-06	3.35e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—BRAF—breast cancer	1.02e-06	3.19e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—DPYD—breast cancer	1.02e-06	3.16e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—MED12—breast cancer	1.02e-06	3.16e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—COMT—breast cancer	1.02e-06	3.16e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GSTP1—breast cancer	1.01e-06	3.14e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ALDOA—breast cancer	1e-06	3.11e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—IGF1—breast cancer	9.98e-07	3.11e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—AKT2—breast cancer	9.97e-07	3.1e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—HMOX1—breast cancer	9.97e-07	3.1e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—ITPR1—breast cancer	9.94e-07	3.09e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—NCOA3—breast cancer	9.71e-07	3.02e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—SLC2A2—breast cancer	9.64e-07	3e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PIK3CD—breast cancer	9.58e-07	2.98e-05	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—MAPK3—breast cancer	9.48e-07	2.95e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—SERPINE1—breast cancer	9.48e-07	2.95e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—MTR—breast cancer	9.44e-07	2.94e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CPT1A—breast cancer	9.44e-07	2.94e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ABCG2—breast cancer	9.44e-07	2.94e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—TYMS—breast cancer	9.4e-07	2.92e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PLA2G4A—breast cancer	9.29e-07	2.89e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GSTM1—breast cancer	9.29e-07	2.89e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—NCOR1—breast cancer	9.29e-07	2.89e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—HPGDS—breast cancer	9.26e-07	2.88e-05	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—MYC—breast cancer	9.22e-07	2.87e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—HBA1—breast cancer	9.2e-07	2.86e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NOS3—breast cancer	9.05e-07	2.82e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GSTT1—breast cancer	8.98e-07	2.8e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ACHE—breast cancer	8.98e-07	2.8e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GPX1—breast cancer	8.89e-07	2.77e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CYP1A1—breast cancer	8.8e-07	2.74e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—ERCC2—breast cancer	8.73e-07	2.72e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—MDM2—breast cancer	8.58e-07	2.67e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—RAF1—breast cancer	8.55e-07	2.66e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—RELA—breast cancer	8.52e-07	2.65e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CYP17A1—breast cancer	8.5e-07	2.65e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—ERBB2—breast cancer	8.46e-07	2.63e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ENO1—breast cancer	8.42e-07	2.62e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PTGS1—breast cancer	8.42e-07	2.62e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—MTOR—breast cancer	8.35e-07	2.6e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PIK3CB—breast cancer	8.35e-07	2.6e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CYP2D6—breast cancer	8.25e-07	2.57e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—MTHFR—breast cancer	8.21e-07	2.55e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—NCOA2—breast cancer	8.1e-07	2.52e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CXCL8—breast cancer	8.02e-07	2.5e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—FASN—breast cancer	7.86e-07	2.45e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CDKN1B—breast cancer	7.84e-07	2.44e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—BCHE—breast cancer	7.83e-07	2.44e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—SLC5A5—breast cancer	7.73e-07	2.41e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CASP3—breast cancer	7.68e-07	2.39e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—IL2—breast cancer	7.67e-07	2.39e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CAV1—breast cancer	7.57e-07	2.36e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CCND1—breast cancer	7.48e-07	2.33e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—SLC2A1—breast cancer	7.47e-07	2.32e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—NQO1—breast cancer	7.47e-07	2.32e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—JUN—breast cancer	7.46e-07	2.32e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CTNNB1—breast cancer	7.4e-07	2.3e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—MMP9—breast cancer	7.26e-07	2.26e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CDKN1A—breast cancer	7.23e-07	2.25e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PTEN—breast cancer	7.22e-07	2.25e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CYP1B1—breast cancer	7.16e-07	2.23e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—MAPK8—breast cancer	7.06e-07	2.2e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—HSP90AA1—breast cancer	7.02e-07	2.18e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PIK3CG—breast cancer	6.9e-07	2.15e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—NCOA1—breast cancer	6.83e-07	2.12e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—STK11—breast cancer	6.73e-07	2.09e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CYP19A1—breast cancer	6.73e-07	2.09e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—SRC—breast cancer	6.69e-07	2.08e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—VEGFA—breast cancer	6.52e-07	2.03e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—STAT3—breast cancer	6.45e-07	2.01e-05	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—AKT1—breast cancer	6.4e-07	1.99e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—COMT—breast cancer	6.26e-07	1.95e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GSTP1—breast cancer	6.23e-07	1.94e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—MAPK3—breast cancer	6.17e-07	1.92e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—HMOX1—breast cancer	6.14e-07	1.91e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ITPR1—breast cancer	6.13e-07	1.91e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PIK3CD—breast cancer	6.06e-07	1.89e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—MYC—breast cancer	6e-07	1.87e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—ALB—breast cancer	5.98e-07	1.86e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TGFB1—breast cancer	5.98e-07	1.86e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ABCB1—breast cancer	5.89e-07	1.83e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—EGFR—breast cancer	5.87e-07	1.83e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—TYMS—breast cancer	5.79e-07	1.8e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—NOS3—breast cancer	5.72e-07	1.78e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GSTM1—breast cancer	5.72e-07	1.78e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—NCOR1—breast cancer	5.72e-07	1.78e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PLA2G4A—breast cancer	5.72e-07	1.78e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—KRAS—breast cancer	5.54e-07	1.72e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GPX1—breast cancer	5.48e-07	1.71e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CYP1A1—breast cancer	5.42e-07	1.69e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ERCC2—breast cancer	5.38e-07	1.67e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PIK3CB—breast cancer	5.28e-07	1.64e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PTGS2—breast cancer	5.24e-07	1.63e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PIK3CA—breast cancer	5.09e-07	1.58e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—MTHFR—breast cancer	5.06e-07	1.57e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TP53—breast cancer	4.92e-07	1.53e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—HRAS—breast cancer	4.71e-07	1.47e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CAV1—breast cancer	4.66e-07	1.45e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PTEN—breast cancer	4.57e-07	1.42e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—IL6—breast cancer	4.51e-07	1.4e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PIK3CG—breast cancer	4.25e-07	1.32e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—AKT1—breast cancer	4.16e-07	1.29e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PIK3CD—breast cancer	3.73e-07	1.16e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ALB—breast cancer	3.69e-07	1.15e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—NOS3—breast cancer	3.53e-07	1.1e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PIK3CB—breast cancer	3.26e-07	1.01e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PTGS2—breast cancer	3.23e-07	1e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PIK3CA—breast cancer	3.22e-07	1e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PTEN—breast cancer	2.81e-07	8.75e-06	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—AKT1—breast cancer	2.63e-07	8.19e-06	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PIK3CA—breast cancer	1.98e-07	6.18e-06	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—AKT1—breast cancer	1.62e-07	5.04e-06	CbGpPWpGaD
